Thermoplastic Resin Composition and Molded Article Manufactured Therefrom
US-2024376301-A1 · Nov 14, 2024 · US
US9447257B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9447257-B2 |
| Application number | US-201514615836-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 6, 2015 |
| Priority date | Feb 10, 2014 |
| Publication date | Sep 20, 2016 |
| Grant date | Sep 20, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
This invention relates to polymer compositions comprising: (1) at least one polymer selected from the groups consisting of: nylon, polyesters, copolyesters, polyethylene, polypropylene, polyamides; polystyrene, polystyrene copolymers, styrene acrylonitrile copolymers, acrylonitrile butadiene styrene copolymers, poly(methylmethacrylate), acrylic copolymers, poly(ether-imides); polyphenylene oxides or poly(phenylene oxide)/polystyrene blends, polystyrene resins; polyphenylene sulfides; polyphenylene sulfide/sulfones; poly(ester-carbonates); polycarbonates; polysulfones; polysulfone ethers; and poly(ether-ketones); or mixtures of any of the other foregoing polymers, and (2) at least one fluoroalkyl derivative.
Opening claim text (preview).
What is claimed is: 1. A polymer composition comprising: (I) at least one polyester which comprises: (a) a dicarboxylic acid component comprising: i) 50 to 100 mole % of terephthalic acid residues; ii) 0 to 50 mole % of aromatic dicarboxylic acid residues having up to 20 carbon atoms; and iii) 0 to 10 mole % of aliphatic dicarboxylic acid residues having up to 16 carbon atoms; and (b) a glycol component comprising 1,4-cyclohexanedimethanol residues, wherein the total mole % of the dicarboxylic acid component is 100 mole %, the total mole % of the glycol component is 100 mole %; and wherein the inherent viscosity of the polyester is from 0.1 to 1.2 dL/g as determined in 60/40 (wt/wt) phenol/tetrachloroethane at a concentration of 0.5 g/100 ml at 25° C.; and (II) at least one fluoroalkyl derivative having the general formula: wherein n=an integer from 8 to 30. 2. The polymer composition of claim 1 comprising ethylene glycol residues. 3. The polymer composition of claim 2 wherein the glycol component comprises 20 to 40 mole % 1,4-cyclohexanedimethanol residues and 60 to 80 mole % ethylene glycol residues. 4. The polymer composition of claim 2 wherein the glycol component comprises 50 to 80 mole % 1,4-cyclohexanedimethanol residues and 20 to 50 mole % ethylene glycol residues. 5. The polymer composition of claim 1 or 2 wherein the glycol component comprises diethylene glycol. 6. The polymer composition of claim 1 wherein the acid component comprising isophthalic acid residues. 7. The polymer composition of claim 6 wherein the acid component comprises 25 to 45 mole % residues of isophthalic acid or an ester thereof. 8. The polymer composition of claim 1 or 2 wherein the acid component comprises 70 to 100 mole % residues of terephthalic acid or an ester thereof. 9. The polymer composition of claim 1 or 2 wherein said fluoroalkyl derivative is mixed with polyethylene. 10. The polymer composition of claim 1 or 2 wherein said fluoroalkyl derivative is present in the amount of 0.01 to 8 weight % based on the total weight percentage of said polyester and said fluroalkyl derivative. 11. The polymer composition of claim 1 or 2 wherein said fluoroalkyl derivative is present in the amount of 0.01 to 5 weight % based on the total weight percentage of said polyester and said fluroalkyl derivative. 12. The polymer composition of claim 1 or 2 which adsorbs at least 5% less fibrinogen compared to the polyester alone according to a fibrinogen ELISA protocol comprising the following steps: (1) incubating the polymer sample in flexural bar form in a phosphate-buffered saline solution containing 0.5 mg/mL of fibrinogen and 2% of bovine serum albumin (w/v) for 5 minutes; (2) removing unbound fibrinogen from the sample bar by washing the bar with phosphate-buffered saline having a pH of 7.3 three times; (3) incubating the sample bar in a non-animal protein blocking agent for 30 minutes at 37° C.; (4) incubating the bar in a 1 μg/mL solution of an anti-fibrinogen horseradish peroxidase antibody-conjugate in a non-animal protein-blocked microtiter plate for 60 minutes at 37° C.; (5) washing the bar four times with a diluted TBST buffer to remove excess non-specific binding of the antibody-conjugate; (6) incubating the bar with an enzyme substrate 3,3′,5,5′-tetramethylbenzidine for 60 minutes; (7) removing the bar from the microplate containing the enzyme substrate; and (8) measuring the absorbance of the enzyme substrate in the microplate well using a microplate spectrophotometer at 630 nanometers to detect conversion of the enzyme substrate to the blue product. 13. The polymer composition of claim 2 which adsorbs from 15% to 45% less fibrinogen compared to the polyester alone. 14. The polymer composition of claim 6 which adsorbs from 5% to 20% less fibrinogen compared to the polyester alone. 15. The polymer compositions of claim 1 or 2 which have a coefficient of friction of less than 0.50 as measured with a Bruker™ tribometer using a 1″×1″×0.125″ plaque on a 4″×4″×0.125″ plaque under a 3 N normal load at 1.2 mm/second. 16. The polymer compositions of claim 1 or 2 which have a coefficient of friction (COF) of 0.10 to 0.50 as measured with a Bruker™ tribometer using a 1″×1″×0.125″ plaque on a 4″×4″×0.125″ plaque under a 3 N normal load at 1.2 mm/second. 17. An article of manufacture made with the polymer composition of claim 1 or 2 . 18. The article of claim 17 which is selected from a medical article, pharmaceutical article, veterinarian article, bioprocessing article, or a food article. 19. The article of claim 17 which is a medical device. 20. The article of claim 19 which is an intravenous component.
containing halogen atoms · CPC title
Acids or hydroxy compounds containing cycloaliphatic rings · CPC title
obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds {(A61L31/041 takes precedence)} · CPC title
Polyesters derived from dicarboxylic acids and dihydroxy compounds (C08L67/06 takes precedence) · CPC title
Sulfonamides · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.